Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Y Wen

Showing results (591-600 of 1,547) with videos related to

Pageof 155
Sort By:
Neurologic Clinics|November 1, 1995
High-grade astrocytomasP Y Wen, H A Fine, P M Black, et al.
Advances in Experimental Medicine and Biology|January 1, 1995
Mechanisms regulating oxytocin receptor coupling to phospholipase C in rat and human myometriumB M Sanborn, A Qian, C Y Ku, et al.
Journal of Neuro-Oncology|April 18, 2014
The role of targeted therapies in the management of progressive glioblastoma : a systematic review and evidence-based clinical practice guidelineJeffrey J Olson, Lakshmi Nayak, D Ryan Ormond, et al.
Mycopathologia|February 1, 1992
AAL toxins, fumonisins (biology and chemistry) and host-specificity conceptsC J Mirocha, D G Gilchrist, W T Shier, et al.
Journal of Pharmaceutical Sciences|May 18, 2007
Enhancing absorption of fluorescein and LHRH across hindgut epithelia in a marsupial, the common brushtail possum Trichosurus vulpeculaJ Y Wen, B J McLeod, I G Tucker, et al.
Neurology|June 1, 1993
Complications of therapy for venous thromboembolic disease in patients with brain tumorsJ M Levin, D Schiff, J S Loeffler, et al.
European Review for Medical and Pharmacological Sciences|December 12, 2018
Down-regulation of microRNA-21 inhibits cell proliferation and invasion of high-invasion liver cancer stem cellsY-C Li, F-M Xu, G-Q Zhang, et al.
Annals of Surgical Oncology|June 1, 2017
Standard Pathologic Features Can Be Used to Identify a Subset of Estrogen Receptor-Positive, HER2 Negative Patients Likely to Benefit from Neoadjuvant ChemotherapyOriana A Petruolo, Melissa Pilewskie, Sujata Patil, et al.
The Journal of Clinical Endocrinology and Metabolism|May 20, 1998
Cytokine-mediated regulation of 92-kilodalton type IV collagenase, tissue inhibitor or metalloproteinase-1 (TIMP-1), and TIMP-3 messenger ribonucleic acid expression in human endometrial stromal cellsH Y Huang, Y Wen, J C Irwin, et al.
Journal of Neurovirology|May 19, 1998
Immune parameters affecting adenoviral vector gene therapy in the brainM J Parr, P Y Wen, M Schaub, et al.
Pageof 155

Showing results (591-600 of 1,547) with videos related to

Sort By:
Pageof 155
Neurologic Clinics|November 1, 1995
High-grade astrocytomasP Y Wen, H A Fine, P M Black, et al.
Advances in Experimental Medicine and Biology|January 1, 1995
Mechanisms regulating oxytocin receptor coupling to phospholipase C in rat and human myometriumB M Sanborn, A Qian, C Y Ku, et al.
Journal of Neuro-Oncology|April 18, 2014
The role of targeted therapies in the management of progressive glioblastoma : a systematic review and evidence-based clinical practice guidelineJeffrey J Olson, Lakshmi Nayak, D Ryan Ormond, et al.
Mycopathologia|February 1, 1992
AAL toxins, fumonisins (biology and chemistry) and host-specificity conceptsC J Mirocha, D G Gilchrist, W T Shier, et al.
Journal of Pharmaceutical Sciences|May 18, 2007
Enhancing absorption of fluorescein and LHRH across hindgut epithelia in a marsupial, the common brushtail possum Trichosurus vulpeculaJ Y Wen, B J McLeod, I G Tucker, et al.
Neurology|June 1, 1993
Complications of therapy for venous thromboembolic disease in patients with brain tumorsJ M Levin, D Schiff, J S Loeffler, et al.
European Review for Medical and Pharmacological Sciences|December 12, 2018
Down-regulation of microRNA-21 inhibits cell proliferation and invasion of high-invasion liver cancer stem cellsY-C Li, F-M Xu, G-Q Zhang, et al.
Annals of Surgical Oncology|June 1, 2017
Standard Pathologic Features Can Be Used to Identify a Subset of Estrogen Receptor-Positive, HER2 Negative Patients Likely to Benefit from Neoadjuvant ChemotherapyOriana A Petruolo, Melissa Pilewskie, Sujata Patil, et al.
The Journal of Clinical Endocrinology and Metabolism|May 20, 1998
Cytokine-mediated regulation of 92-kilodalton type IV collagenase, tissue inhibitor or metalloproteinase-1 (TIMP-1), and TIMP-3 messenger ribonucleic acid expression in human endometrial stromal cellsH Y Huang, Y Wen, J C Irwin, et al.
Journal of Neurovirology|May 19, 1998
Immune parameters affecting adenoviral vector gene therapy in the brainM J Parr, P Y Wen, M Schaub, et al.
Pageof 155